Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of modified-release doxazosin vs originator Doxazosin XL in healthy Thai volunteers (fasted, fed, multiple dose)
TCTR20190215003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of doxazosin in hypertension (HTN) and benign prostatic hyperplasia (BPH) (6 arms), sponsored by Bio-innova. Planned start May 2019; status: not yet recruiting.
02
Drugs
doxazosin
03
Conditions
hypertension (HTN)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on TCTR20190215003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190215003.